| Literature DB >> 26729381 |
Gill Hubbard1, Richard Adams2, Anna Campbell3, Lisa Kidd4, Stephen J Leslie5, Julie Munro1, Angus Watson6.
Abstract
OBJECTIVES: (1) Assess whether cardiac rehabilitation (CR) is a feasible and acceptable model of rehabilitation for postsurgical colorectal cancer (CRC) survivors, (2) evaluate trial procedures. This article reports the results of the first objective. DESIGN ANDEntities:
Keywords: REHABILITATION MEDICINE
Mesh:
Year: 2016 PMID: 26729381 PMCID: PMC4716214 DOI: 10.1136/bmjopen-2015-009284
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Flow chart (CR,cardiac rehabilitation; CRC, colorectal cancer).
Comparison of three cardiac rehabilitation sites (TIDieR)
| Intervention component | Site 1 | Site 2 | Site 3 |
|---|---|---|---|
| WHAT—materials | BHF booklets | BHF booklets | BHF booklets |
| WHAT—procedures | 1:1 initial assessment | 1:1 initial assessment | 2:1 initial assessment |
| WHO | Cardiac PT | Cardiac physiotherapist | Specialist physiotherapist |
| HOW | Group classes 15–20 per class | Group classes 15–25 per class | Group classes (maximum 15 patients) |
| WHERE | Hospital gym | Hospital or sports centre | Sports centre |
| WHEN and HOW MUCH (dose) |
CR, cardiac rehabilitation; ISWT, Incremental Shuttle Walk Test; PT, physiotherapist; TIDieR, Template for Intervention Description and Replication.
Key topic areas explored relating to intervention feasibility and acceptability
| Health professionals | Patients with CRC | CVD groups | |
|---|---|---|---|
| Barriers | |||
| Travel/distance | ✓ | ✓ | ✓ |
| Recovery from surgery | ✓ | ✓ | ✓ |
| Stoma | ✓ | ✓ | |
| Adjuvant therapy | ✓ | ✓ | |
| CR as part of routine care | ✓ | ✓ | ✓ |
| Mixed patient classes | ✓ | ✓ | ✓ |
| Capability of group | ✓ | ✓ | |
| Capacity of services | ✓ | ✓ | ✓ |
| Gaps in support | ✓ | ✓ | ✓ |
| Reasons for taking part | ✓ | ||
| Randomisation process | ✓ | ||
| Study information | ✓ | ||
| Data collection | ✓ | ✓ | |
CR, cardiac rehabilitation; CRC, colorectal cancer; CVD, cardiovascular disease.
Reasons for declining to participate (n=33)
| Reason | All sites |
|---|---|
| Distance/travel barriers | 2 (6%) |
| Return to normal activities | 3 (9%) |
| Clinical, for example, poor recovery from surgery, comorbidity | 9 (28%) |
| Other commitments/time | 2 (6%) |
| Adjuvant therapy | 6 (18%) |
| Study time limit | 3 (9%) |
| Unable to contact | 1 (3%) |
| Patient death | 1 (3%) |
| Missing | 6 (18%) |
Adherence and attendance by site
| Number of sessions | Adherence (%) | Attendance (%) | |
|---|---|---|---|
| Site 1 | 1/week for 10 weeks=10 | 83 | 100 |
| Site 2 | 1–2 weeks for 12 weeks=12–24 | 56 | 107 |
| Site 3 | 2 weeks for 12 weeks=12 | 50 | 92 |